MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: news
news

Novel Peripheral Retinal Vascular Biomarker on Ultra-Widefield OCTA Enables Severity Grading in Retinitis Pigmentosa

MedXY Editorial TeamAug 24, 2026
peripheral retinal vasculatureultra-widefield OCT angiographydisease severity grading

Highlight

  • Identification of two distinct peripheral retinal vascular phenotypes in retinitis pigmentosa (RP) via ultra-widefield OCT angiography (UWF-OCTA): Terminal Remodeling and Simple Atrophy.
  • Validation of the chorioretinal neovascular zone (CNZ) area as a robust quantitative biomarker correlating strongly with multiple visual function measures.
  • Development and validation of a clinically applicable four-stage severity grading system based on CNZ area reliably stratifying RP disease progression.
  • Potential for the grading system to enhance disease monitoring and patient stratification in future interventional trials.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story